Showing 1 - 10 of 10
This benchmarking project investigated 57 processes of industrial authorisation in 11 countries and regions. A number of benchmarks and best practices were identified and a number of recommendations for improvement were developed.
Persistent link: https://www.econbiz.de/10005059321
What has happened to the economy in Styria over the past two decades could be described as a case history of regional rehabilitation. Looking at employment only, we find a restructurization process drawn out over more than 30 years, at the temporary end of which there are more new jobs created...
Persistent link: https://www.econbiz.de/10005031518
Persistent link: https://www.econbiz.de/10012131577
For Austrian agriculture, eastern enlargement as envisaged by the European Union once again translates into a challenge. On balance, farmers need to expect losses of market share and pressure on prices, which in turn should accelerate structural change in the Austrian agricultural sector.
Persistent link: https://www.econbiz.de/10005001132
Agriculture is among the delicate items of the envisaged EU eastern enlargement. Major differences between western Europe and the Central and Eastern European candidate countries in terms of agricultural potential, agricultural structure, performance level of food industry, and agricultural...
Persistent link: https://www.econbiz.de/10005059355
The agricultural sector was considered a sensitive area with regard to EU integration. Nevertheless, the transition to the single market was accomplished without serious market disruptions. Farm incomes have risen. Generous public assistance has facilitated the changeover, although it has...
Persistent link: https://www.econbiz.de/10005059363
Objective: To estimate the 3-year incremental cost effectiveness and cost utility of introducing leflunomide into sequential therapy, consisting of the most frequently used disease-modifying antirheumatic drugs (DMARDs), for patients with rheumatoid arthritis in specialised, i.e....
Persistent link: https://www.econbiz.de/10005590474
Objective: To quantify direct costs of medication and cost of illness (according to functional capacity) for patients with rheumatoid arthritis (RA) in Germany, allowing further use in a health economic evaluation of sequential therapy with disease-modifying antirheumatic drugs (DMARDs) in...
Persistent link: https://www.econbiz.de/10005590526